Cargando…
S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
Autores principales: | Frede, Julia, Poller, Julia, Shi, Kayleen, Stuart, Hannah, Sotoudeh, Noori, Lim, Klothilda, Wiggers, Caroline, Waldschmidt, Johannes, Dimitrova, Valeriya, Montanaro, Anna, Cho, Eugene, Vijaykumar, Tushara, Richardson, Paul, Munshi, Nikhil, Anderson, Kenneth, Martin, Nathan, Kaiser, Shari, Raab, Marc-Steffen, Knoechel, Birgit, Lohr, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428259/ http://dx.doi.org/10.1097/01.HS9.0000967664.04864.bb |
Ejemplares similares
-
P324: CELL PLASTICITY PREDETERMINES TREATMENT RESPONSE IN T-ALL
por: Dimitrova, Valeriya, et al.
Publicado: (2023) -
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma
por: Frede, Julia, et al.
Publicado: (2021) -
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
por: Li, Li, et al.
Publicado: (2023) -
Cell-free DNA for the detection of emerging treatment failure in relapsed/refractory multiple myeloma
por: Waldschmidt, Johannes M., et al.
Publicado: (2022) -
Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013)